nodes	percent_of_prediction	percent_of_DWPC	metapath
Remoxipride—DRD4—Gilles de la Tourette syndrome	0.311	0.342	CbGaD
Remoxipride—DRD3—Gilles de la Tourette syndrome	0.268	0.295	CbGaD
Remoxipride—DRD2—Gilles de la Tourette syndrome	0.185	0.204	CbGaD
Remoxipride—HTR2A—Gilles de la Tourette syndrome	0.143	0.158	CbGaD
Remoxipride—DRD4—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00564	0.0755	CbGpPWpGaD
Remoxipride—DRD4—Dopamine receptors—DRD2—Gilles de la Tourette syndrome	0.00511	0.0682	CbGpPWpGaD
Remoxipride—DRD3—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00487	0.0651	CbGpPWpGaD
Remoxipride—DRD3—Dopamine receptors—DRD2—Gilles de la Tourette syndrome	0.00453	0.0606	CbGpPWpGaD
Remoxipride—DRD2—Dopamine receptors—DRD3—Gilles de la Tourette syndrome	0.00384	0.0513	CbGpPWpGaD
Remoxipride—DRD2—Dopamine receptors—DRD4—Gilles de la Tourette syndrome	0.00372	0.0498	CbGpPWpGaD
Remoxipride—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00226	0.21	CbGeAlD
Remoxipride—Alizapride—DRD2—Gilles de la Tourette syndrome	0.00212	0.285	CrCbGaD
Remoxipride—DRD4—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.00179	0.0239	CbGpPWpGaD
Remoxipride—DRD4—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.00162	0.0216	CbGpPWpGaD
Remoxipride—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00154	0.0206	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00146	0.0196	CbGpPWpGaD
Remoxipride—DRD3—Nicotine Activity on Dopaminergic Neurons—DRD2—Gilles de la Tourette syndrome	0.00144	0.0192	CbGpPWpGaD
Remoxipride—Amisulpride—DRD3—Gilles de la Tourette syndrome	0.00144	0.193	CrCbGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0013	0.0174	CbGpPWpGaD
Remoxipride—Sulpiride—DRD3—Gilles de la Tourette syndrome	0.00126	0.169	CrCbGaD
Remoxipride—DRD4—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00125	0.0167	CbGpPWpGaD
Remoxipride—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD3—Gilles de la Tourette syndrome	0.00122	0.0163	CbGpPWpGaD
Remoxipride—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—Gilles de la Tourette syndrome	0.00118	0.0158	CbGpPWpGaD
Remoxipride—DRD4—Hypothetical Network for Drug Addiction—DRD2—Gilles de la Tourette syndrome	0.00116	0.0155	CbGpPWpGaD
Remoxipride—DRD4—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00113	0.0151	CbGpPWpGaD
Remoxipride—DRD4—brain—Gilles de la Tourette syndrome	0.00111	0.103	CbGeAlD
Remoxipride—DRD3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00108	0.0144	CbGpPWpGaD
Remoxipride—DRD4—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00105	0.014	CbGpPWpGaD
Remoxipride—DRD3—nervous system—Gilles de la Tourette syndrome	0.00102	0.095	CbGeAlD
Remoxipride—DRD3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.001	0.0134	CbGpPWpGaD
Remoxipride—Amisulpride—DRD2—Gilles de la Tourette syndrome	0.000994	0.133	CrCbGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.000994	0.0133	CbGpPWpGaD
Remoxipride—DRD3—central nervous system—Gilles de la Tourette syndrome	0.000985	0.0915	CbGeAlD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.000978	0.0131	CbGpPWpGaD
Remoxipride—DRD4—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000948	0.0127	CbGpPWpGaD
Remoxipride—DRD3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000904	0.0121	CbGpPWpGaD
Remoxipride—Sulpiride—DRD2—Gilles de la Tourette syndrome	0.000869	0.117	CrCbGaD
Remoxipride—DRD2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000848	0.0113	CbGpPWpGaD
Remoxipride—DRD2—Hypothetical Network for Drug Addiction—DRD4—Gilles de la Tourette syndrome	0.000844	0.0113	CbGpPWpGaD
Remoxipride—DRD3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000842	0.0113	CbGpPWpGaD
Remoxipride—HTR2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.000834	0.0112	CbGpPWpGaD
Remoxipride—DRD2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.000823	0.011	CbGpPWpGaD
Remoxipride—HTR2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00081	0.0108	CbGpPWpGaD
Remoxipride—DRD4—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00079	0.0106	CbGpPWpGaD
Remoxipride—DRD3—brain—Gilles de la Tourette syndrome	0.000782	0.0726	CbGeAlD
Remoxipride—Amisulpride—HTR2A—Gilles de la Tourette syndrome	0.000768	0.103	CrCbGaD
Remoxipride—HTR2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.000754	0.0101	CbGpPWpGaD
Remoxipride—DRD2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000713	0.00953	CbGpPWpGaD
Remoxipride—DRD3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000702	0.00938	CbGpPWpGaD
Remoxipride—HTR2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000701	0.00937	CbGpPWpGaD
Remoxipride—DRD2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000692	0.00925	CbGpPWpGaD
Remoxipride—HTR2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000681	0.0091	CbGpPWpGaD
Remoxipride—DRD4—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000664	0.00888	CbGpPWpGaD
Remoxipride—SIGMAR1—midbrain—Gilles de la Tourette syndrome	0.000652	0.0605	CbGeAlD
Remoxipride—HTR2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000634	0.00848	CbGpPWpGaD
Remoxipride—DRD3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00059	0.00789	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000554	0.00741	CbGpPWpGaD
Remoxipride—DRD2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000537	0.00718	CbGpPWpGaD
Remoxipride—DRD2—midbrain—Gilles de la Tourette syndrome	0.000526	0.0489	CbGeAlD
Remoxipride—DRD3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000478	0.00639	CbGpPWpGaD
Remoxipride—DRD2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000451	0.00603	CbGpPWpGaD
Remoxipride—DRD2—nervous system—Gilles de la Tourette syndrome	0.000433	0.0402	CbGeAlD
Remoxipride—DRD2—central nervous system—Gilles de la Tourette syndrome	0.000417	0.0387	CbGeAlD
Remoxipride—SIGMAR1—brain—Gilles de la Tourette syndrome	0.000409	0.038	CbGeAlD
Remoxipride—HTR2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000371	0.00495	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00036	0.00481	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000351	0.00469	CbGpPWpGaD
Remoxipride—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000347	0.0323	CbGeAlD
Remoxipride—DRD2—brain—Gilles de la Tourette syndrome	0.000331	0.0307	CbGeAlD
Remoxipride—DRD3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000312	0.00417	CbGpPWpGaD
Remoxipride—DRD4—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.000294	0.00393	CbGpPWpGaD
Remoxipride—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000285	0.0265	CbGeAlD
Remoxipride—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000275	0.0255	CbGeAlD
Remoxipride—DRD4—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000266	0.00355	CbGpPWpGaD
Remoxipride—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.00026	0.0242	CbGeAlD
Remoxipride—DRD4—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000259	0.00347	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000253	0.00339	CbGpPWpGaD
Remoxipride—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00025	0.0233	CbGeAlD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000241	0.00322	CbGpPWpGaD
Remoxipride—DRD3—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000236	0.00316	CbGpPWpGaD
Remoxipride—DRD4—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000235	0.00314	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000224	0.00299	CbGpPWpGaD
Remoxipride—HTR2A—brain—Gilles de la Tourette syndrome	0.000218	0.0203	CbGeAlD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000218	0.00291	CbGpPWpGaD
Remoxipride—DRD3—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000208	0.00279	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000208	0.00277	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000206	0.00276	CbGpPWpGaD
Remoxipride—DRD2—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.0002	0.00267	CbGpPWpGaD
Remoxipride—CYP2D6—brain—Gilles de la Tourette syndrome	0.000199	0.0185	CbGeAlD
Remoxipride—DRD2—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000194	0.00259	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000193	0.00258	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000187	0.00249	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000178	0.00238	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000176	0.00236	CbGpPWpGaD
Remoxipride—DRD2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000171	0.00229	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000166	0.00221	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000164	0.00219	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000161	0.00215	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000159	0.00212	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000157	0.0021	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000156	0.00209	CbGpPWpGaD
Remoxipride—DRD4—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000152	0.00204	CbGpPWpGaD
Remoxipride—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000146	0.00195	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000142	0.0019	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00014	0.00187	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000138	0.00184	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000136	0.00182	CbGpPWpGaD
Remoxipride—DRD3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000135	0.00181	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000135	0.00181	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000134	0.00179	CbGpPWpGaD
Remoxipride—DRD4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000131	0.00175	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000126	0.00169	CbGpPWpGaD
Remoxipride—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000125	0.00167	CbGpPWpGaD
Remoxipride—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000116	0.00155	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000107	0.00143	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000105	0.0014	CbGpPWpGaD
Remoxipride—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000104	0.00139	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000104	0.00139	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000102	0.00136	CbGpPWpGaD
Remoxipride—DRD4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.95e-05	0.00133	CbGpPWpGaD
Remoxipride—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	9.5e-05	0.00127	CbGpPWpGaD
Remoxipride—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	8.88e-05	0.00119	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.88e-05	0.00119	CbGpPWpGaD
Remoxipride—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	8.84e-05	0.00118	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.06e-05	0.00108	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.03e-05	0.00107	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	7.65e-05	0.00102	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.29e-05	0.000974	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.13e-05	0.000953	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	6.95e-05	0.000929	CbGpPWpGaD
Remoxipride—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	6.76e-05	0.000904	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.47e-05	0.000865	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	6.03e-05	0.000806	CbGpPWpGaD
Remoxipride—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	5.97e-05	0.000798	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	5.94e-05	0.000793	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.86e-05	0.000783	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	5.76e-05	0.00077	CbGpPWpGaD
Remoxipride—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.62e-05	0.000751	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.48e-05	0.000732	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	5.39e-05	0.000721	CbGpPWpGaD
Remoxipride—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	5.37e-05	0.000718	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.32e-05	0.000711	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	5.23e-05	0.000699	CbGpPWpGaD
Remoxipride—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.11e-05	0.000682	CbGpPWpGaD
Remoxipride—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	4.99e-05	0.000668	CbGpPWpGaD
Remoxipride—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	4.88e-05	0.000652	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.76e-05	0.000636	CbGpPWpGaD
Remoxipride—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.53e-05	0.000606	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.31e-05	0.000576	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.11e-05	0.000549	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	3.82e-05	0.000511	CbGpPWpGaD
Remoxipride—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	3.82e-05	0.000511	CbGpPWpGaD
Remoxipride—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	3.47e-05	0.000464	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.24e-05	0.000433	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	3.18e-05	0.000426	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.14e-05	0.00042	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	3.09e-05	0.000413	CbGpPWpGaD
Remoxipride—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.02e-05	0.000403	CbGpPWpGaD
Remoxipride—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.88e-05	0.000385	CbGpPWpGaD
Remoxipride—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.68e-05	0.000358	CbGpPWpGaD
Remoxipride—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.05e-05	0.000274	CbGpPWpGaD
